The Filings Report

DARLING INGREDIENTS INC.

DARNYSECIK 916540Consumer Defensive / Packaged Foods & Farm Productsfiscal year ends December69 quarters since 2009

Revenue, Q2 FY2026
$1.7B
+16.4% on Q2 FY2025
Net income
$387M
+2959.1% on Q2 FY2025
Free cash flow
—
no year-earlier figure
Diluted EPS
$2.41
+2912.5% on Q2 FY2025
Revenue, TTM
$6.5B
trailing four quarters
Net margin, TTM
9.1%
net income $598M
Free cash flow, TTM
—
Cash and equivalents
$161M
long-term debt —, Jul 4, 2026
Shares, 12-month change
−0.2%
158M shares, Jul 4, 2026
Buybacks, TTM
$73M
0.9% of market value
Dividends, TTM
—
no yield
Market value
$7.9B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 7, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended July 4, 2026, DARLING INGREDIENTS INC. reported revenue of $1.7B, +16.4% on Q2 FY2025, and net income of $387M (+2959.1%). Operating margin was 32.2%. Diluted earnings per share were $2.41.

Share price

Daily candlesticks from November 11, 2024 to November 6, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

DAR daily priceSplit-adjusted, US dollars; an earnings release
Nov 6, 2026O $51.27 · H $51.77 · L $50.05 · C $50.19 · −1.01% on the dayOver the range: +57.24%, Nov 7, 2025 to Nov 6, 2026
$29$40$51$62$72Nov 25Jan 26Apr 26Jun 26Aug 26Nov 26

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 7, 2026.

Revenue and net incomeRevenueNet income
−$500M$0$500M$1.0B$1.5B$2.0BQ3'22, Revenue: $1.7BQ3'22, Net income: $191MQ3'22Q4'22, Revenue: $1.8BQ4'22, Net income: $157MQ4'22Q1'23, Revenue: $1.8BQ1'23, Net income: $186MQ1'23Q2'23, Revenue: $1.8BQ2'23, Net income: $252MQ2'23Q3'23, Revenue: $1.6BQ3'23, Net income: $125MQ3'23Q4'23, Revenue: $1.6BQ4'23, Net income: $85MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $81MQ1'24Q2'24, Revenue: $1.5BQ2'24, Net income: $79MQ2'24Q3'24, Revenue: $1.4BQ3'24, Net income: $17MQ3'24Q4'24, Revenue: $1.4BQ4'24, Net income: $102MQ4'24Q1'25, Revenue: $1.4BQ1'25, Net income: −$26MQ1'25Q2'25, Revenue: $1.5BQ2'25, Net income: $13MQ2'25Q3'25, Revenue: $1.6BQ3'25, Net income: $19MQ3'25Q4'25, Revenue: $1.7BQ4'25, Net income: $57MQ4'25Q1'26, Revenue: $1.6BQ1'26, Net income: $134MQ1'26Q2'26, Revenue: $1.7BQ2'26, Net income: $387MQ2'26−$500M$0$500M$1.0B$1.5B$2.0BQ3'22, Revenue: $1.7BQ3'22, Net income: $191MQ3'22Q4'22, Revenue: $1.8BQ4'22, Net income: $157MQ4'22Q1'23, Revenue: $1.8BQ1'23, Net income: $186MQ1'23Q2'23, Revenue: $1.8BQ2'23, Net income: $252MQ2'23Q3'23, Revenue: $1.6BQ3'23, Net income: $125MQ3'23Q4'23, Revenue: $1.6BQ4'23, Net income: $85MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $81MQ1'24Q2'24, Revenue: $1.5BQ2'24, Net income: $79MQ2'24Q3'24, Revenue: $1.4BQ3'24, Net income: $17MQ3'24Q4'24, Revenue: $1.4BQ4'24, Net income: $102MQ4'24Q1'25, Revenue: $1.4BQ1'25, Net income: −$26MQ1'25Q2'25, Revenue: $1.5BQ2'25, Net income: $13MQ2'25Q3'25, Revenue: $1.6BQ3'25, Net income: $19MQ3'25Q4'25, Revenue: $1.7BQ4'25, Net income: $57MQ4'25Q1'26, Revenue: $1.6BQ1'26, Net income: $134MQ1'26Q2'26, Revenue: $1.7BQ2'26, Net income: $387MQ2'26−$500M$0$500M$1.0B$1.5B$2.0BQ3'22, Revenue: $1.7BQ3'22, Net income: $191MQ4'22, Revenue: $1.8BQ4'22, Net income: $157MQ4'22Q1'23, Revenue: $1.8BQ1'23, Net income: $186MQ2'23, Revenue: $1.8BQ2'23, Net income: $252MQ2'23Q3'23, Revenue: $1.6BQ3'23, Net income: $125MQ4'23, Revenue: $1.6BQ4'23, Net income: $85MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $81MQ2'24, Revenue: $1.5BQ2'24, Net income: $79MQ2'24Q3'24, Revenue: $1.4BQ3'24, Net income: $17MQ4'24, Revenue: $1.4BQ4'24, Net income: $102MQ4'24Q1'25, Revenue: $1.4BQ1'25, Net income: −$26MQ2'25, Revenue: $1.5BQ2'25, Net income: $13MQ2'25Q3'25, Revenue: $1.6BQ3'25, Net income: $19MQ4'25, Revenue: $1.7BQ4'25, Net income: $57MQ4'25Q1'26, Revenue: $1.6BQ1'26, Net income: $134MQ2'26, Revenue: $1.7BQ2'26, Net income: $387MQ2'26

Net income losses drawn in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$50M$100M$150M$200MQ3'22, Cash and equivalents: $126MQ3'22Q4'22, Cash and equivalents: $127MQ4'22Q1'23, Cash and equivalents: $133MQ1'23Q2'23, Cash and equivalents: $112MQ2'23Q3'23, Cash and equivalents: $119MQ3'23Q4'23, Cash and equivalents: $127MQ4'23Q1'24, Cash and equivalents: $145MQ1'24Q2'24, Cash and equivalents: $122MQ2'24Q3'24, Cash and equivalents: $115MQ3'24Q4'24, Cash and equivalents: $76MQ4'24Q1'25, Cash and equivalents: $81MQ1'25Q2'25, Cash and equivalents: $95MQ2'25Q3'25, Cash and equivalents: $91MQ3'25Q4'25, Cash and equivalents: $89MQ4'25Q1'26, Cash and equivalents: $116MQ1'26Q2'26, Cash and equivalents: $161MQ2'26$0$50M$100M$150M$200MQ3'22, Cash and equivalents: $126MQ3'22Q4'22, Cash and equivalents: $127MQ4'22Q1'23, Cash and equivalents: $133MQ1'23Q2'23, Cash and equivalents: $112MQ2'23Q3'23, Cash and equivalents: $119MQ3'23Q4'23, Cash and equivalents: $127MQ4'23Q1'24, Cash and equivalents: $145MQ1'24Q2'24, Cash and equivalents: $122MQ2'24Q3'24, Cash and equivalents: $115MQ3'24Q4'24, Cash and equivalents: $76MQ4'24Q1'25, Cash and equivalents: $81MQ1'25Q2'25, Cash and equivalents: $95MQ2'25Q3'25, Cash and equivalents: $91MQ3'25Q4'25, Cash and equivalents: $89MQ4'25Q1'26, Cash and equivalents: $116MQ1'26Q2'26, Cash and equivalents: $161MQ2'26$0$50M$100M$150M$200MQ3'22, Cash and equivalents: $126MQ4'22, Cash and equivalents: $127MQ4'22Q1'23, Cash and equivalents: $133MQ2'23, Cash and equivalents: $112MQ2'23Q3'23, Cash and equivalents: $119MQ4'23, Cash and equivalents: $127MQ4'23Q1'24, Cash and equivalents: $145MQ2'24, Cash and equivalents: $122MQ2'24Q3'24, Cash and equivalents: $115MQ4'24, Cash and equivalents: $76MQ4'24Q1'25, Cash and equivalents: $81MQ2'25, Cash and equivalents: $95MQ2'25Q3'25, Cash and equivalents: $91MQ4'25, Cash and equivalents: $89MQ4'25Q1'26, Cash and equivalents: $116MQ2'26, Cash and equivalents: $161MQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 7, 2026.

DARLING INGREDIENTS INC. income statement, quarterly
Millions of dollarsQ2 FY2026ended Jul 4, 2026filed Aug 7, 2026Q1 FY2026ended Apr 4, 2026filed May 8, 2026Q4 FY2025ended Jan 3, 2026filed Mar 3, 2026Q3 FY2025ended Sep 27, 2025filed Nov 5, 2025Q2 FY2025ended Jun 28, 2025filed Aug 6, 2025Q1 FY2025ended Mar 29, 2025filed May 7, 2025Q4 FY2024ended Dec 28, 2024filed Feb 25, 2025Q3 FY2024ended Sep 28, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue1,7241,5511,7101,5641,4821,3811,4181,422+16.4%
Cost of revenue1,2211,1461,2811,1771,1361,0691,0841,108+7.5%
Gross profit503405429387346311334314+45.5%
Research and development—————————
Selling, general and administrative151149152140138122108116+9.3%
Operating income5552279772762812260+631.8%
Other income (expense)(57)(54)(54)(55)(60)(56)(47)(62)+4.7%
Pretax income500176482018(25)782+2627.3%
Income tax11139(11)(1)4(1)(26)(17)+2621.7%
Net income387134571913(26)10217+2959.1%
Diluted EPS ($)2.410.83—0.120.08(0.16)—0.11+2912.5%
Diluted shares (millions)161161—160160159—161—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 7, 2026.

DARLING INGREDIENTS INC. balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jul 4, 2026filed Aug 7, 2026Q1 FY2026ended Apr 4, 2026filed May 8, 2026Q4 FY2025ended Jan 3, 2026filed Mar 3, 2026Q3 FY2025ended Sep 27, 2025filed Nov 5, 2025Q2 FY2025ended Jun 28, 2025filed Aug 6, 2025Q1 FY2025ended Mar 29, 2025filed May 7, 2025Q4 FY2024ended Dec 28, 2024filed Feb 25, 2025Q3 FY2024ended Sep 28, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents1611168991958176115+70.0%
Short-term investments—————————
Total current assets1,7571,6461,5531,5031,4951,4551,4391,497+17.5%
Total assets10,98410,64110,29910,45210,27510,03210,07010,573+6.9%
Total current liabilities1,1231,0401,0351,0109971,0361,0441,063+12.7%
Long-term debt—————————
Total liabilities5,6785,6975,4895,6835,5825,4965,6065,938+1.7%
Stockholders’ equity5,2464,8764,7374,6894,6134,4484,3784,551+13.7%
Shares outstanding (millions)158159159158158158159159—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 7, 2026.

DARLING INGREDIENTS INC. cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jul 4, 2026filed Aug 7, 2026Q1 FY2026ended Apr 4, 2026filed May 8, 2026Q4 FY2025ended Jan 3, 2026filed Mar 3, 2026Q3 FY2025ended Sep 27, 2025filed Nov 5, 2025Q2 FY2025ended Jun 28, 2025filed Aug 6, 2025Q1 FY2025ended Mar 29, 2025filed May 7, 2025Q4 FY2024ended Dec 28, 2024filed Feb 25, 2025Q3 FY2024ended Sep 28, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow533153441224146249154274+265.9%
Capital expenditures—————————
Free cash flow (CFO − capex)—————————
Depreciation and amortization130131140124121124128124+7.5%
Share repurchases7300003550—
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed March 3, 2026.

Income statement

DARLING INGREDIENTS INC. income statement, annual
Millions of dollarsFY2025ended Jan 3, 2026filed Mar 3, 2026FY2024ended Dec 28, 2024filed Feb 25, 2025FY2023ended Dec 30, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 27, 2023FY2021ended Jan 1, 2022filed Mar 1, 2022FY2020ended Jan 2, 2021filed Mar 2, 2021FY2019ended Dec 28, 2019filed Feb 25, 2020FY2018ended Dec 29, 2018filed Feb 27, 2019FY2017ended Dec 30, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Jan 2, 2016filed Mar 1, 2016FY2014ended Jan 3, 2015filed Mar 4, 2015FY2013ended Dec 28, 2013filed Feb 26, 2014FY2012ended Dec 29, 2012filed Feb 27, 2013FY2011ended Dec 31, 2011filed Feb 29, 2012FY2010ended Jan 1, 2011filed Mar 2, 2011FY2009ended Jan 2, 2010filed Aug 12, 2010FY2008ended Jan 3, 2009filed Aug 12, 2010
Revenue6,1365,7156,7886,5324,7413,5723,3643,3883,6623,3923,3913,9561,8021,7731,797725598807
Cost of revenue4,6624,4375,1435,0033,4992,6892,5892,6462,8762,6352,6543,1231,3401,3041,268532440615
Gross profit1,4731,2781,6451,530——————————————
Research and development——————————————————
Selling, general and administrative551492543437392378359309344312316375171152136686160
Operating income2734689501,029884431476255169155143165170232314827193
Other income (expense)(225)(233)(235)(140)(69)(81)(96)(136)(106)(103)(117)(149)(14)(22)(40)(12)(4)(3)
Pretax income61248720894821354380118641239981164207272706790
Income tax(9)(38)60147164535912(69)1514135576103262535
Net income632796487386512973131011281027964109131169444255
Diluted EPS ($)0.391.733.994.493.901.781.860.600.770.620.480.390.911.111.470.530.510.66
Diluted shares (millions)1601611621641671671681681671651651651201181168382—

Balance sheet

DARLING INGREDIENTS INC. balance sheet, annual
Millions of dollarsFY2025ended Jan 3, 2026filed Mar 3, 2026FY2024ended Dec 28, 2024filed Feb 25, 2025FY2023ended Dec 30, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 27, 2023FY2021ended Jan 1, 2022filed Mar 1, 2022FY2020ended Jan 2, 2021filed Mar 2, 2021FY2019ended Dec 28, 2019filed Feb 25, 2020FY2018ended Dec 29, 2018filed Feb 27, 2019FY2017ended Dec 30, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Jan 2, 2016filed Mar 1, 2016FY2014ended Jan 3, 2015filed Mar 4, 2015FY2013ended Dec 28, 2013filed Feb 26, 2014FY2012ended Dec 29, 2012filed Feb 27, 2013FY2011ended Dec 31, 2011filed Feb 29, 2012FY2010ended Jan 1, 2011filed Mar 2, 2011FY2009ended Jan 2, 2010filed Aug 12, 2010FY2008ended Jan 3, 2009filed Aug 12, 2010
Cash and equivalents897612712769827310710711515710987110339396851
Short-term investments——————————————————
Total current assets1,5531,4391,8561,6381,0899879178989568939321,0091,128290220186146—
Total assets10,29910,07011,0619,2026,1345,6135,3454,8894,9584,6984,7615,1273,2441,5521,4171,382426—
Total current liabilities1,0351,0449981,06875367568854055945244248317713212715571—
Long-term debt——————————1,8862,09886725028070728—
Total liabilities5,4895,6066,3675,3062,7862,6592,7022,5542,6312,6222,7863,0751,223490497918141—
Stockholders’ equity4,7374,3784,6053,8093,2812,8922,5662,2732,2451,9731,8711,9532,0211,062920464285237
Shares outstanding (millions)159159160160161163164165165165164165164118117117——

Cash flow statement

DARLING INGREDIENTS INC. cash flow statement, annual
Millions of dollarsFY2025ended Jan 3, 2026filed Mar 3, 2026FY2024ended Dec 28, 2024filed Feb 25, 2025FY2023ended Dec 30, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 27, 2023FY2021ended Jan 1, 2022filed Mar 1, 2022FY2020ended Jan 2, 2021filed Mar 2, 2021FY2019ended Dec 28, 2019filed Feb 25, 2020FY2018ended Dec 29, 2018filed Feb 27, 2019FY2017ended Dec 30, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Jan 2, 2016filed Mar 1, 2016FY2014ended Jan 3, 2015filed Mar 4, 2015FY2013ended Dec 28, 2013filed Feb 26, 2014FY2012ended Dec 29, 2012filed Feb 27, 2013FY2011ended Dec 31, 2011filed Feb 29, 2012FY2010ended Jan 1, 2011filed Mar 2, 2011FY2009ended Jan 2, 2010filed Aug 12, 2010FY2008ended Jan 3, 2009filed Aug 12, 2010
Operating cash flow1,060839899814704625363399410391421275211250241827992
Capital expenditures38033255539127428035932227424423022911811560252431
Free cash flow (CFO − capex)6795073444224303453771361471914692134181575661
Depreciation and amortization509504502395316350326321302290270270998579322524
Share repurchases3534531261685519005600—————
Dividends paid——————————————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 9, 2024 to November 9, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$2M
8 sales by 5 insiders; officers and directors $2M
Bought, twelve months
$61K
2 purchases by 1 insider; officers and directors $61K
Sold, twelve months
$5M
19 sales by 6 insiders; officers and directors $5M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Sep 2, 2026Stuewe Randall CChairman and CEO, Directoropen-market sale5,000$68.20$341K1MSep 4, 2026
Aug 18, 2026Manzi JosephChief Accounting Officeropen-market sale1,000$67.27$67K18,969Aug 18, 2026
Aug 17, 2026Dudley SandraEVP Chief Strategy Officeroption exercise5,928$18.82$112K84,036Aug 18, 2026
Aug 17, 2026Dudley SandraEVP Chief Strategy Officertax withholding3,330$67.88$226K80,706Aug 18, 2026
Aug 17, 2026Dudley SandraEVP Chief Strategy Officeropen-market sale2,598$67.88$176K78,108Aug 18, 2026
Aug 17, 2026Dudley SandraEVP Chief Strategy Officeropen-market sale3,876$67.87$263K74,232Aug 18, 2026
Aug 14, 2026McNutt PatrickEVP Chief Admin Officeropen-market sale8,000$67.09$537K35,777Aug 14, 2026
Aug 13, 2026Stuewe Randall CChairman and CEO, Directoropen-market sale5,000$64.79$324K1MAug 14, 2026
Aug 12, 2026Stuewe Randall CChairman and CEO, Directoropen-market sale5,000$63.26$316K1MAug 14, 2026
Aug 10, 2026Kemphaus Nicholas JamesEVP Gen. Counsel & Secretaryopen-market sale1,591$63.05$100K35,087Aug 10, 2026
Jul 31, 2026Adair Charles LDirectoropen-market buy500$60.67$30K51,190Aug 3, 2026
Jul 31, 2026Adair Charles LDirectoropen-market buy500$61.27$31K51,690Aug 3, 2026
May 7, 2026Hill Randy LDirectoraward2,650$0.00—15,525May 14, 2026
May 7, 2026Hill Randy LDirectoraward701$37.64$26K16,226May 14, 2026
May 7, 2026Schroder SorenDirectoraward2,650$0.00—12,825May 8, 2026
May 7, 2026Schroder SorenDirectoraward261$37.64$10K13,086May 8, 2026
May 7, 2026Stoffel KurtDirectoraward2,650$0.00—21,139May 8, 2026
May 7, 2026Hill Randy LDirectoraward2,650$0.00—15,525May 8, 2026
May 7, 2026Hill Randy LDirectoraward261$37.64$10K15,786May 8, 2026
May 7, 2026Guimaraes EndersonDirectoraward2,650$0.00—21,095May 8, 2026
May 7, 2026Goodspeed LindaDirectoraward2,650$0.00—42,836May 8, 2026
May 7, 2026Clark Celeste A.Directoraward2,650$0.00—20,437May 8, 2026
May 7, 2026Clark Celeste A.Directoraward130$37.64$5K20,567May 8, 2026
May 7, 2026Barden LarryDirectoraward2,650$0.00—34,847May 8, 2026
May 7, 2026Barden LarryDirectoraward261$37.64$10K35,108May 8, 2026

Full insider history for DARLING INGREDIENTS INC., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
DARLING INGREDIENTS INC., CIK 916540 on EDGAR
Extract generated
November 8, 2026
Withheld
8 line-years whose four quarters do not sum to the filed year: revenue FY2012, cost of revenue FY2013, cost of revenue FY2014, net income FY2016, pretax income FY2016, revenue FY2016, operating income FY2017, buybacks FY2020
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: net income FY2016
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: not filed
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated November 8, 2026.

JSON file
/data/financials/DAR.json